<SEC-DOCUMENT>0000886163-22-000069.txt : 20220613
<SEC-HEADER>0000886163-22-000069.hdr.sgml : 20220613
<ACCEPTANCE-DATETIME>20220613084428
ACCESSION NUMBER:		0000886163-22-000069
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20220613
DATE AS OF CHANGE:		20220613
EFFECTIVENESS DATE:		20220613

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-265545
		FILM NUMBER:		221010780

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ligand-formsx8june2022.htm
<DESCRIPTION>S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie060336cbec845f2899081c622cf52e7_1"></div><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As filed with the Securities and Exchange Commission on June 13, 2022</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registration No. 333-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;________</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:7pt double #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</font></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Washington, D.C. 20549</font></div><div style="padding-left:78.29pt;padding-right:78.29pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">__________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center;text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM S-8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">UNDER</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">THE SECURITIES ACT OF 1933</font></div><div style="padding-left:78.29pt;padding-right:78.29pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Its Charter)</font></div><div style="text-align:center;text-indent:0.18pt"><font><br></font></div><div style="text-align:center;text-indent:0.18pt"><font><br></font></div><div style="text-align:center;text-indent:0.18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delaware</font></td><td colspan="3" style="padding:0 2.12pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77-0160744</font></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(State or other jurisdiction of</font></td><td colspan="3" style="padding:0 2.12pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(I.R.S. Employer</font></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">incorporation or organization)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Identification No.)</font></td></tr></table></div><div style="text-align:center;text-indent:0.18pt"><font><br></font></div><div style="text-align:center;text-indent:0.18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.617%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5980 Horton Street, Suite 405</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Emeryville</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94608</font></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Address of principal executive offices)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Zip Code)</font></td></tr></table></div><div style="text-align:center;text-indent:0.18pt"><font><br></font></div><div style="text-align:center;text-indent:0.18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, as amended and restated</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">Non-Qualified Inducement Stock Option Grant Notice and Stock Option Agreement</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> (Full title of the plans)</font></div><div style="padding-left:78.29pt;padding-right:78.29pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">John L. Higgins </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">Chief Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">Ligand Pharmaceuticals Incorporated </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">5980 Horton Street, Suite 405</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">Emeryville, CA  94608</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:104%">(Name and address of agent for service)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:104%">(858) 550-7500</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:104%">(Telephone number, including area code, of agent for service)</font></div><div style="text-align:center;text-indent:18pt"><font><br></font></div><div style="padding-left:78.29pt;padding-right:78.29pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">____________________________</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Copies to&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew T. Bush, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anthony Gostanian, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Latham &#38; Watkins LLP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12670 High Bluff Drive</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">San Diego, CA  92130</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(858) 523-5400</font></div><div style="text-align:center;text-indent:18pt"><font><br></font></div><div style="padding-left:78.29pt;padding-right:78.29pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________________</font></div><div style="padding-right:-7.75pt;text-align:center"><font><br></font></div><div style="padding-right:-15.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</font></div><div style="padding-right:-15.5pt"><font><br></font></div><div style="height:47.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.788%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large Accelerated Filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(do not check if a smaller reporting company)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></td></tr></table></div><div><font><br></font></div><div style="padding-right:-15.5pt"><font><br></font></div><div style="padding-right:-15.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</font></div><div style="padding-right:-7.75pt;text-align:center"><font><br></font></div><div style="height:47.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ie060336cbec845f2899081c622cf52e7_4"></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXPLANATORY NOTE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Registration Statement on Form S-8 registers the offer and sale of (i) an additional 1,000,000 shares of common stock available for issuance under the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, as amended and restated (the &#8220;2002 Plan&#8221;) and (ii) 40,000 shares of common stock issued to Kurt Gustafson under the Non-Qualified&#160;Inducement Stock Option Grant Notice and Stock Option Agreement, dated April  8, 2022 (the &#8220;Inducement Option Agreement&#8221;).   </font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We previously filed a Registration Statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000095013706000420/a16037orsv1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form S-1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (File No. 333-131029) with the Securities and Exchange Commission (the &#8220;Commission&#8221;), to register shares of common stock available for issuance under the 2002 Plan at a time when Ligand was not eligible to file a Registration Statement on Form S-8. However, Ligand later became eligible to file a Registration Statement on Form S-8 and opted to file a Post-Effective Amendment No. 2 on Form S-8 to the Registration Statement on Form S-1 for the purpose of converting the Registration Statement on Form S-1 into a Registration Statement on Form S-8.  Please see the Registration Statement on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000095013706000420/a16037orsv1.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form S-1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> filed with the Commission on January 13, 2006, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000093639206000109/a16037a1sv1za.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1 to Form S-1</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Registration Statement filed with the Commission on February 10, 2006, Post-Effective Amendment No. 2 on Form S-8 to Form S-1 Registration Statement filed with the Commission on June 18, 2007 for further detail.  In accordance with Instruction E to Form S-8, the contents of these prior registration statements and the registration statements on Form S-8, File No.&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000119312512295007/d374814ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-182547</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000119312509134320/ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-160132</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616304000012/s82004.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-117129</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616303000024/s82003.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-106375</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616302000013/s82002.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-91414</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000119312516664653/d164308ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-212775</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/lgnd-formsx8amendmentandre.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-233130</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and File No. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0000886163/000119312521019279/d916648ds8.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">333-252480</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> previously filed with respect to the 2002 Plan, are hereby incorporated by reference.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The documents containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) of the Securities Act. These documents and the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of this Registration Statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II</font></div><div><font><br></font></div><div style="text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 3. Incorporation of Documents by Reference.</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Commission allows us to incorporate by reference the information we file with it, which means that we can disclose important information to you by referring to those documents. The information incorporated by reference is an important part of this Registration Statement, and information that we file later with the Commission will automatically update and supersede this information. We incorporate by reference the following documents we have filed, or may file, with the Commission&#58;</font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)&#160;&#160;&#160;&#160;the description of our common stock contained in our Registration Statement on Form 8-A filed with the Commission on November&#160;21, 1994, and any amendment or report filed for the purpose of updating such description&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)&#160;&#160;&#160;&#160;our Annual Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886163/000088616322000030/lgnd-20211231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form 10-K</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the fiscal year ended December&#160;31, 2021 filed with the Commission on February&#160;28, 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)&#160;&#160;&#160;&#160;our Quarterly Report on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886163/000088616322000049/lgnd-20220331.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Form 10-Q</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the fiscal quarter ended March&#160;31, 2022 filed with the Commission on May&#160;9, 2022&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)&#160;&#160;&#160;&#160;our Current Reports on Form 8-K filed with the Commission on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886163/000088616322000003/lgnd-20220114.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">January 14, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000886163/000088616322000006/lgnd-20220126.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">January 27</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2022, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886163/000119312522082890/d341975d8k.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 23, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/886163/000119312522083443/d337089d8k.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 24, 2022</a></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)&#160;&#160;&#160;&#160;all documents filed by us with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), after the date of this Registration Statement and prior to the termination of this offering of securities.</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any statement incorporated herein shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. Under no circumstances will any information filed under current item 2.02 or 7.01 of Form 8-K or related exhibits furnished pursuant to current item 9.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font><br></font></div><div><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4. Description of Securities.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not applicable.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5. Interests of Named Experts and Counsel.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not applicable.</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 6. Indemnification of Directors and Officers.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsection (a) of Section 145 of the General Corporation Law of the State of Delaware (referred to as the &#8220;DGCL&#8221;) empowers a corporation to indemnify any person who was or is a party or who is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsection (b) of Section 145 empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person acted in any of the capacities set forth above, against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 145 further provides that to the extent a director or officer of a corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to in subsections (a) and (b) of Section 145, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith&#59; that indemnification provided for by Section 145 shall not be deemed exclusive of any other rights to which the indemnified party may be entitled&#59; and the indemnification provided for by Section 145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of such person&#8217;s heirs, executors and administrators. Section 145 also empowers the corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his status as such, whether or not the corporation would have the power to indemnify such person against such liabilities under Section 145.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 102(b)(7) of the DGCL provides that a corporation&#8217;s certificate of incorporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director (i) for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL or (iv) for any transaction from which the director derived an improper personal benefit.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our amended and restated certificate of incorporation provides for indemnification of its directors, officers, employees and other agents to the maximum extent permitted by the DGCL, and our bylaws provide for indemnification of its directors, officers, employees and other agents to the maximum extent permitted by the DGCL.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, we have entered into separate indemnification agreements with our directors and officers which may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements may require us, among other things, to indemnify our officers and directors against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements also may require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. In addition, we have purchased a </font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">policy of directors&#8217; and officers&#8217; liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</font></div><div style="text-indent:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7. Exemption from Registration Claimed.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not applicable.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8. Exhibits.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:6.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.139%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Exhibit<br>Number</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Exhibit Description</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Incorporated by Reference</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Filed<br>Herewith</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Form</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">File No.</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Exhibit</font></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Filing Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/0000936392-98-001000.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation of the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S-4</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-58823</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">07&#47;09&#47;1998</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</a><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">2</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fourth Amended and Restated Bylaws of the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-33093</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#47;30&#47;2020</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.</a><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company dated June 14, 2000</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">000-20720</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">03&#47;29&#47;2001</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616304000015/ex3-6.txt" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.4</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company dated June&#160;30, 2004</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-Q</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">000-20720</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">08&#47;05&#47;2004</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000119312510264942/dex31.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.5</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated November&#160;17, 2010</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8-K</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-33093</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#47;19&#47;2010</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/exhibit36.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">3.6</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 19, 2018</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S-8</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-233130</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">08&#47;08&#47;2019</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgndexhibi41.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Specimen stock certificate for shares of the common stock of the Company</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-33093</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">03&#47;01&#47;2018</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:12pt;text-indent:-12pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000025/exh43lgnddescriptionofse.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">4.2</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description of Registered Securities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10-K</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-33093</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">02&#47;24&#47;2021</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8_exhibit51.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">5.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opinion of Latham &#38; Watkins LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/886163/000119312520291679/d79683ddef14a.htm#toc79683_13" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">10.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2002 Stock Incentive Plan, as amended and restated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEF 14A</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-33093</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Appendix A</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">04&#47;22&#47;2022</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8_exhibit102.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">10.2</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Qualified&#160;Inducement Stock Option Grant Notice and Stock Option Agreement dated April  8, 2022 by and between the Company and Kurt Gustafson</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8_exhibit231.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">23.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of Ernst &#38; Young LLP, independent registered public accounting firm</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8_exhibit51.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">23.2</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of Latham &#38; Watkins LLP (included in Exhibit&#160;5.1 hereto)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="#ie060336cbec845f2899081c622cf52e7_95" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">24.1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Power of Attorney (see signature page)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="s-8_exhibit107.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">107</a></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Calculation of Filing Fee Table</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9. Undertakings.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">The undersigned Registrant hereby undertakes&#58;</font></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement&#58;</font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.1pt;text-align:justify;text-indent:-9.55pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.57pt">To include any prospectus required by Section 10(a)(3) of the Securities Act&#894;</font></div><div style="margin-top:0.05pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%;padding-left:5.8pt">To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#59; and</font></div><div style="margin-top:0.3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%;padding-left:3.03pt">To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement&#59;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:128%">&#160;&#160;&#160;&#160;provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">, that the undertakings set forth in paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.</font></div><div style="margin-top:0.25pt;text-align:justify;text-indent:-9.55pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-top:0.05pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%;padding-left:6.34pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%;padding-left:6.34pt">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:128%">bona fide </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">offering thereof.</font></div><div style="margin-top:0.25pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:128%;padding-left:6.91pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="ie060336cbec845f2899081c622cf52e7_95"></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 13, 2022.</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%">   </font></div><div style="padding-left:253.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.602%"><tr><td style="width:1.0%"></td><td style="width:10.390%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:0.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:0.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:0.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">John L. Higgins</font></div><div style="padding-left:0.4pt;padding-right:0.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr></table></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:234pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">        </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints John L. Higgins, Matthew Korenberg and Charles S. Berkman, and each of them acting individually, as his or her attorney-in-fact, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8 (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or any substitute, may do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       </font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.835%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Title</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Date</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;John L. Higgins</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director (Principal Executive Officer)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Matthew Korenberg</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Officer (Principal Financial </font></div><div style="margin-bottom:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Officer and Principal Accounting Officer)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;John W. Kozarich&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John W. Kozarich</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Jason M. Aryeh&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason M. Aryeh</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Sarah Boyce&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sarah Boyce</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Jennifer Cochran&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer Cochran</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Todd C. Davis&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Todd C. Davis</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Nancy Ryan Gray&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nancy Ryan Gray</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;John L. LaMattina&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. LaMattina</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Sunil Patel&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunil Patel</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;&#160;&#160;&#160;&#160;Stephen L. Sabba&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;&#160;</font></div><div style="margin-bottom:0.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen L. Sabba</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 13, 2022</font></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="height:43.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>s-8_exhibit107.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id2009703c1ab443783802c4c0c4a3b30_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 107</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CALCULATION OF FILING FEE TABLE</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font><br></font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form S-8</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Form Type)</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font><br></font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ligand Pharmaceuticals Incorporated</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font><br></font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Table 1&#58; Newly Registered Securities</font></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font><br></font></div><div style="padding-left:0.07pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Security Type</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Security</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Class</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Title</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Fee</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Calculation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Rule</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Amount to be</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Registered (1)</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Proposed</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Maximum</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Offering</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Price Per</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Share </font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Proposed Maximum</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Aggregate</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Offering</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Price</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Fee</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Rate</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Amount of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Registration</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:124%">Fee</font></div></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:124%">Equity</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:124%">Common Stock, $0.001 par value per share</font></div></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rule 457(c) and Rule 457(h)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000,000 (2)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$83.33(3)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$83,330,000 (3)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$92.70 per $1,000,000</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$7,724.69</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center;text-indent:-10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:124%">Equity</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:124%">Common Stock, $0.001 par value per share</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rule 457(h)</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,000 (4)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$117.06 (5)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$4,682,400 (5)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$92.70 per $1,000,000</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$434.06</font></td></tr><tr><td colspan="21" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Offering Amounts</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$88,012,400</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$8,158.75</font></td></tr><tr><td colspan="21" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Fee Offsets (6)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0</font></td></tr><tr><td colspan="21" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net Fee Due</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$8,158.75</font></td></tr></table></div><div style="padding-left:3pt;padding-right:3pt;text-align:center"><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of Common Stock, par value $0.001 (&#8220;Common Stock&#8221;), of Ligand Pharmaceuticals Incorporated (the &#8220;Registrant&#8221;) that become issuable under the Registrant&#8217;s Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, as amended and restated (the &#8220;Plan&#8221;) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents 1,000,000 shares of Common Stock authorized for future issuance under the Plan.  </font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Estimated in accordance with Rule 457(c) and Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee.  The maximum price per share and maximum aggregate offering price are based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on June 6, 2022, which date is within five business days prior to filing this Registration Statement.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents 40,000 shares of Common Stock issuable upon exercise of stock options granted to Kurt Gustafson, Chief Financial Officer of OmniAb, Inc., a subsidiary of the Registrant, pursuant to the&#160;Non-Qualified&#160;Inducement Stock Option Grant Notice and Stock Option Agreement, dated April 8, 2022 (the &#8220;Inducement Option Agreement&#8221;).   </font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The proposed maximum offer price per share has been determined pursuant to Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share is $117.06 per share, which is the exercise price of options granted under the Inducement Option Agreement.</font></div><div style="padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Registrant does not have any fee offsets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>s-8_exhibit51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if31547982c454733be2236a9e8598e5a_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Exhibit 5.1</font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="lwheadera.jpg" src="lwheadera.jpg" style="height:287px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">June 13, 2022 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Ligand Pharmaceuticals Incorporated</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">5980 Horton Street, Suite 405</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Emeryville, CA 94608</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Re&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">        </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Registration Statement on Form S-8&#58; 1,040,000 Shares of Common Stock, par value $0.001 per share </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">To the addressees set forth above&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">              </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We have acted as special counsel to Ligand Pharmaceuticals Incorporated, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;), in connection with the proposed issuance of 1,000,000 shares of common stock, par value $0.001 per share, of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;), issuable pursuant to the Company&#8217;s 2002 Stock Incentive Plan, as amended and restated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">2002 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) and 40,000 shares of Common Stock (together with the shares of Common Stock issuable pursuant to the 2002 Plan, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;), issuable pursuant to that certain Non-Qualified Inducement Stock Option Grant Notice and Stock Option Agreement dated April 8, 2022 by and between the Company and Kurt Gustafson (the &#8220;Inducement Option Agreement&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;), filed with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;) on June 13, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, other than as expressly stated herein with respect to the issue of the Shares.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">With your consent, we have relied upon certificates and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We are opining herein only as to the General Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as copies.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the recipients, or certificates representing the Shares have been manually signed by an authorized officer of the transfer agent and registrar therefor, and subject to the Company completing all actions and proceedings required on its part to be taken prior to the issuance of the Shares, and when the Shares have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the 2002 Plan or the Inducement Option Agreement, the issuance and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">We consent to your filing this opinion as an exhibit to the Registration Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Very truly yours,</font></div><div><font><br></font></div><div style="text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#47;s&#47; Latham &#38; Watkins LLP</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>s-8_exhibit102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib52cbecceeed40db834c5c7ee5f9fee9_45"></div><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">NOTICE OF GRANT OF NON-QUALIFIED INDUCEMENT STOCK OPTION  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">              </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As inducement material to the decision by the individual listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to accept employment with OmniAb, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">OmniAb</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), a subsidiary of Ligand Pharmaceuticals Incorporated (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Corporation hereby grants to Optionee a non-qualified stock option to purchase the number of shares (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of Common Stock of the Corporation set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Option is subject to the terms and conditions set forth in this Notice of Grant of Non-Qualified Inducement Stock Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Non-Qualified Inducement Stock Option Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which is incorporated herein by reference.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Option is made and granted as a stand-alone award and is not granted under or pursuant to the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, as amended and restated effective December 15, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                                    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kurt Gustafson</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">April 8, 2022</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">March 21, 2022</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$117.06</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Number of Option Shares&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,000</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expiration Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                          </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">April 7, 2032</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Type of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">                                           </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-Qualified Stock Option</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Schedule&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Twelve and one-half percent (12.5%) of the Option Shares subject to the Option shall vest on the six (6) month anniversary of the Vesting Commencement Date, and one forty-eighth (1&#47;48th) of the Option Shares subject to the Option shall vest on each monthly anniversary thereafter, so that all of the Shares subject to the Option shall be vested on the fourth (4th) anniversary of the Vesting Commencement Date, subject to Optionee&#8217;s Service with the Corporation and&#47;or OmniAB, Inc. on each applicable vesting date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">              </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment at Will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing in this Grant Notice or in the attached Stock Option Agreement shall confer upon Optionee any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to terminate Optionee&#8217;s Service at any time for any reason, with or without cause.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">              </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All capitalized terms in this Grant Notice shall have the meaning assigned to them in this Grant Notice or in the attached Stock Option Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For convenience purposes only, capitalized terms not defined in the Grant Notice or in the Stock Option Agreement shall have the meaning assigned to them in the Plan. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By accepting Optionee&#8217;s signature below, Optionee agrees to be bound by the terms and conditions of this Grant Notice and the Stock Option Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Optionee has reviewed this Grant Notice and the Stock Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing the Grant Notice and fully understands all provisions of this Grant Notice and the Stock Option Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant hereby agrees to accept as binding, conclusive and final all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">decision and interpretations of the Plan Administrator upon any questions arising under this Grant Notice and the Stock Option Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Ligand Pharmaceuticals Incorporated</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Optionee</font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">By&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Print Name&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Print Name&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Kurt Gustafson</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div id="ib52cbecceeed40db834c5c7ee5f9fee9_1"></div><div style="margin-top:3.35pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-top:3.35pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</font></div><div style="margin-top:0.1pt;padding-right:-15pt"><font><br></font></div><div style="padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">NON-QUALIFIED INDUCEMENT STOCK OPTION AGREEMENT</font></div><div style="padding-right:-15pt"><font><br></font></div><div style="margin-top:0.3pt;padding-right:-15pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">RECITALS</font></div><div style="margin-top:0.45pt;padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">In consideration of Participant&#8217;s agreement to commence employment with and remain in the employ of the Corporation (or a Parent or Subsidiary), and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice, the Corporation has granted to Optionee an option to purchase the Option Shares set forth in the Grant Notice.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%;padding-left:26.84pt">All capitalized terms in this Agreement shall have the meaning assigned to them in the attached Appendix.</font></div><div style="margin-top:0.45pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOW, THEREFORE, it is hereby agreed as follows&#58;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt"> GRANT OF OPTION.  The Corporation hereby grants to Optionee, as of the Grant Date, an option to purchase up to the number of Option Shares specified in the Grant Notice.  The Option Shares shall be purchasable from time to time during the option term specified in Paragraph 2 at the Exercise Price. </font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">The option is made and granted as a stand-alone award and apart from, and outside of, the Plan, and shall not constitute an award granted under or pursuant to the Plan. Notwithstanding the foregoing, the terms, conditions and definitions set forth in the Plan shall apply to the option (including but not limited to the adjustment provisions contained in Article One, Section V.D of the Plan), and the option shall be subject to such terms, conditions and definitions set forth in the Plan which are hereby incorporated into this Agreement by reference.  For the avoidance of doubt, the option shall not be counted for purposes of calculating the aggregate number of Shares that may be issued or transferred pursuant to Awards under the Plan as set forth in Article One, Section V.A of the Plan. In the event of any inconsistency between the Plan and this Agreement, the terms of this Agreement shall control. </font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">The option is intended to constitute an &#8220;employment inducement grant&#8221; under NASDAQ Listing Rule 5635(c)(4), and consequently is intended to be exempt from the NASDAQ rules regarding stockholder approval of stock option and stock purchase plans.  This Agreement and the terms and conditions of the option shall be interpreted in accordance and consistent with such exemption.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">OPTION TERM.  This option shall have a maximum term of ten (10) years measured from the Grant Date and shall accordingly expire at the close of business on the Expiration Date, unless sooner terminated in accordance with Paragraph 5 or 6.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">LIMITED TRANSFERABILITY.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">This option shall be neither transferable nor assignable by Optionee other than by will or the laws of inheritance following Optionee&#8217;s death and may be exercised, during Optionee&#8217;s lifetime, only by Optionee.  However, Optionee may designate one or more persons as the beneficiary or beneficiaries of this option, and this option shall, in accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee&#8217;s death while holding this option.  Such beneficiary or beneficiaries shall take the transferred </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">option subject to all the terms and conditions of this Agreement, including (without limitation) the limited time period during which this option may, pursuant to Paragraph 5, be exercised following Optionee&#8217;s death.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">This option may be assigned in whole or in part during Optionee&#8217;s lifetime to one or more members of Optionee&#8217;s family or to a trust established for the exclusive benefit of one or more such family members or to Optionee&#8217;s former spouse, to the extent such assignment is in connection with the Optionee&#8217;s estate plan or pursuant to a domestic relations order.  The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment.  The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">DATES OF EXERCISE.  This option shall become exercisable for the Option Shares in one or more installments as specified in the Grant Notice.  As the option becomes exercisable for such installments, those installments shall accumulate, and the option shall remain exercisable for the accumulated installments until the Expiration Date or sooner termination of the option term under Paragraph 5 or 6.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">CESSATION OF SERVICE.  The option term specified in Paragraph 2 shall terminate (and this option shall cease to be outstanding) prior to the Expiration Date should any of the following provisions become applicable&#58;</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Should Optionee cease to remain in Service for any reason (other than death or Permanent Disability) while this option is outstanding, then Optionee (or any person or persons to whom this option is transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of three (3) months (commencing with the date of such cessation of Service) during which to exercise this option, but in no event shall this option be exercisable at any time after the Expiration Date.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Should Optionee die while this option is outstanding, then the personal representative of Optionee&#8217;s estate or the person or persons to whom the option is transferred pursuant to Optionee&#8217;s will or the laws of inheritance following Optionee&#8217;s death or to whom the option is transferred during Optionee&#8217;s lifetime pursuant to a permitted transfer under Paragraph 3 shall have the right to exercise this option.  However, if Optionee dies while holding this option and has an effective beneficiary designation in effect for this option at the time of his or her death, then the designated beneficiary or beneficiaries shall have the exclusive right to exercise this option following Optionee&#8217;s death.  Any such right to exercise this option shall lapse, and this option shall cease to be outstanding, upon the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">earlier</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> of (i) the expiration of the twelve (12)-month period measured from the date of Optionee&#8217;s death or (ii) the Expiration Date.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">Should Optionee cease Service by reason of Permanent Disability while this option is outstanding, then Optionee (or any person or persons to whom this option is transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of twelve (12) months (commencing with the date of such cessation of Service) during which to exercise this option.  In no event shall this option be exercisable at any time after the Expiration Date.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">During the limited period of post-Service exercisability, this option may not be exercised in the aggregate for more than the number of Option Shares for which the option is exercisable at the time of Optionee&#8217;s cessation of Service.  Upon the expiration of such limited exercise period or (if earlier) upon the Expiration Date, this option shall terminate and cease to be outstanding for any exercisable Option Shares for which the option has not been exercised.  However, this option shall, immediately upon Optionee&#8217;s cessation of Service for any reason, terminate and cease to be outstanding with respect to any Option Shares for which this option is not otherwise at that time exercisable.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">SPECIAL ACCELERATION OF OPTION.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">This option, to the extent outstanding at the time of a Change in Control but not otherwise fully exercisable, shall automatically accelerate so that this option shall, immediately prior to the effective date of such Change in Control, become exercisable for all of the Option Shares at the time subject to this option and may be exercised for any or all of those Option Shares as fully vested shares of Common Stock.  However, this option shall not become exercisable on such an accelerated basis, if and to the extent&#58; (i) this option is to be assumed by the successor corporation (or parent thereof) or is otherwise to be continued in full force and effect pursuant to the terms of the Change in Control transaction or (ii) this option is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing at the time of the Change in Control on any Option Shares for which this option is not otherwise at that time exercisable (the excess of the Fair Market Value of those Option Shares over the aggregate Exercise Price payable for such shares) and provides for subsequent payout of that spread in accordance with the same option exercise&#47;vesting schedule for those Option Shares set forth in the Grant Notice.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">Immediately following the Change in Control, this option shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in effect pursuant to the terms of the Change in Control transaction.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">If this option is assumed in connection with a Change in Control or otherwise continued in effect, then this option shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to Optionee in consummation of such Change in Control had the option been exercised immediately prior to such Change in Control, and appropriate adjustments shall also be made to the Exercise Price, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the aggregate Exercise Price shall remain the same.  To the extent the actual holders of the Corporation&#8217;s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption of this option, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control.</font></div><div style="margin-top:0.15pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">This Agreement shall not in any way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">ADJUSTMENT IN OPTION SHARES.  The option shall be subject to adjustment as provided in Article One, Section V.D of the Plan.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">STOCKHOLDER RIGHTS.  The holder of this option shall not have any stockholder rights with respect to the Option Shares until such person shall have exercised the option, paid the Exercise Price and become a holder of record of the purchased shares.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:28.5pt">MANNER OF EXERCISING OPTION.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">In order to exercise this option with respect to all or any part of the Option Shares for which this option is at the time exercisable, Optionee (or any other person or persons exercising the option) must take the following actions&#58;</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">Execute and deliver to the Corporation a Notice of Exercise for the Option Shares for which the option is exercised.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">Pay the aggregate Exercise Price for the purchased shares in one or more of the following forms&#58;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.12pt">cash or check made payable to the Corporation (includes cash paid from Optionee&#8217;s brokerage pursuant to a presale of shares in a so-called &#8220;cashless&#8221; exercise)&#59;</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.68pt">subject to the consent of the Plan Administrator, shares of Common Stock held by Optionee (or any other person or persons exercising the option) for the requisite period necessary to avoid a charge to the Corporation&#8217;s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date&#59;</font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.68pt">shares of Common Stock issuable upon the exercise of the option having a Fair Market Value on the Exercise Date equal to the aggregate exercise price of the Option Shares with respect to which the option or portion thereof is being exercised&#59; or</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.12pt">through a special sale and remittance procedure pursuant to which Optionee (or any other person or persons exercising the option) shall concurrently provide irrevocable instructions (i) to a brokerage firm to effect the immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate Exercise Price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Corporation by reason of such exercise and (ii) to the Corporation to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale.</font></div><div style="margin-top:0.4pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="margin-top:3pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:117%">Except to the extent the sale and remittance procedure is utilized in connection with the option exercise, payment of the Exercise Price must accompany the Notice of Exercise delivered to the Corporation in connection with the option exercise.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">Furnish to the Corporation appropriate documentation that the person or persons exercising the option (if other than Optionee) have the right to exercise this option.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Make appropriate arrangements with the Corporation (or Parent or Subsidiary employing or retaining Optionee) for the satisfaction of all applicable income and employment tax withholding requirements applicable to the option exercise, which amounts may be paid in on or more of the forms of consideration permitted under clause (ii) above, subject to Article Six, Section I of the Plan and any required consent of the Plan Administrator under clause (ii) above.  To the extent any employment tax withholding will be satisfied by Optionee pursuant to clause (B) or (C) under clause (ii) above, the shares to be surrendered to the Corporation or withheld from the shares of Common Stock otherwise issuable upon the exercise shall be limited to those shares with a Fair Market Value not exceeding the amount necessary to satisfy the tax withholding obligation of the Corporation with respect to the exercise of the option based on the minimum applicable statutory withholding rates.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">As soon as practical after the Exercise Date, the Corporation shall issue to or on behalf of Optionee (or any other person or persons exercising this option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto.</font></div><div style="padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">In no event may this option be exercised for any fractional shares.</font></div><div style="margin-top:0.1pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">COMPLIANCE WITH LAWS AND REGULATIONS.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.91pt">The exercise of this option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Corporation and Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange (including The Nasdaq Stock Market, if applicable) on which the Common Stock may be listed for trading at the time of such exercise and issuance.</font></div><div style="margin-top:0.2pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">The inability of the Corporation to obtain approval from any regulatory body having authority deemed by the Corporation to be necessary to the lawful issuance and sale of any Common Stock pursuant to this option shall relieve the Corporation of any liability with respect to the non-issuance or sale of the Common Stock as to which such approval shall not have been obtained.  The Corporation, however, shall use its best efforts to obtain all such approvals.</font></div><div style="margin-top:0.05pt;padding-right:-1pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">SUCCESSORS AND ASSIGNS.  Except to the extent otherwise provided in Paragraphs 3 and 6, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Corporation and its successors and assigns and Optionee, Optionee&#8217;s assigns, the legal representatives, heirs and legatees of Optionee&#8217;s estate and any beneficiaries of this option designated by Optionee.</font></div><div style="margin-top:12pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">NOTICES.  Any notice required to be given or delivered to the Corporation under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal corporate offices.  Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the most recent address for Optionee on the Corporation&#8217;s payroll records.  All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified.</font></div><div style="padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">CONSTRUCTION.  All decisions of the Plan Administrator with respect to any question or issue arising under the Option, the Grant Notice or this Agreement shall be conclusive and binding on all persons having an interest in this option.</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.5pt">GOVERNING LAW.  The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of California without resort to that State&#8217;s conflict-of-laws rules.</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ib52cbecceeed40db834c5c7ee5f9fee9_4"></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="margin-top:3.35pt;padding-right:-7.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">APPENDIX</font></div><div style="margin-top:0.5pt;padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="padding-right:-15pt;text-indent:36pt"><font><br></font></div><div style="margin-top:1.4pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:218%">The following definitions shall be in effect under the Agreement&#58; </font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">AGREEMENT shall mean this Non-Qualified Inducement Stock Option Agreement.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">BOARD shall mean the Corporation&#8217;s Board of Directors.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt">CHANGE IN CONTROL shall mean a change in ownership or control of the Corporation effected through any of the following transactions&#58;</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">a merger, consolidation or other reorganization approved by the Corporation&#8217;s stockholders, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">unless</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Corporation&#8217;s outstanding voting securities immediately prior to such transaction, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">the sale, transfer or other disposition of all or substantially all of the Corporation&#8217;s assets in complete liquidation or dissolution of the Corporation, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">the acquisition, directly or indirectly by any person or related group of persons (other than the Corporation or a person that directly or indirectly controls, is controlled by, or is under common control with, the Corporation), of beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Corporation&#8217;s outstanding securities pursuant to a tender or exchange offer made directly to the Corporation&#8217;s stockholders.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">COMMON STOCK shall mean shares of the Corporation&#8217;s common stock. </font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt">CODE shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">CORPORATION shall mean Ligand Pharmaceuticals Incorporated, a Delaware corporation, and any successor corporation to all or substantially all of the assets or voting stock of Ligand Pharmaceuticals Incorporated which shall by appropriate action assume the Option.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">EMPLOYEE shall mean an individual who is in the employ of the Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:30.17pt">EXERCISE DATE shall mean the date on which the option shall have been exercised in accordance with Paragraph 9 of the Agreement.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:29.61pt">EXERCISE PRICE shall mean the exercise price per Option Share as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">EXPIRATION DATE shall mean the date on which the option expires as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">FAIR MARKET VALUE per share of Common Stock on any relevant date shall be determined in accordance with the following provisions&#58;</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">If the Common Stock is at the time traded on The Nasdaq Stock Market, then the Fair Market Value shall be deemed equal to the closing selling price per share of Common Stock on the date in question, as the price is reported by the National Association of Securities Dealers on The Nasdaq Stock Market and published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists, or</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">If the Common Stock is at the time listed on any Stock Exchange, then the Fair Market Value shall be deemed equal to the closing selling price per share of Common Stock on the date in question on the Stock Exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange and published in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Wall Street Journal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.61pt">GRANT DATE shall mean the date of grant of the option as specified in the Grant Notice.</font></div><div style="height:76.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> Exhibit 10.2</font></div></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">GRANT NOTICE shall mean the Notice of Grant of Non-Qualified Inducement Stock Option accompanying the Agreement, pursuant to which Optionee has been informed of the basic terms of the option evidenced hereby.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">O.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">INDEPENDENT DIRECTOR shall mean a director of the Corporation who is not an employee of the Corporation and who qualifies as &#8220;independent&#8221; within the meaning of NASDAQ Stock Market Rule 5605(a)(2), or any successor rule, if the Corporation&#8217;s securities are traded on the NASDAQ Stock Market, and&#47;or the applicable requirements of any other established stock exchange on which the Corporation&#8217;s securities are traded, as applicable, as such rules and requirements may be amended from time to time.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt">NON-EMPLOYEE DIRECTOR shall mean a director of the Corporation who qualifies as a &#8220;Non-Employee Director&#8221; as defined in Rule 16b-3(b)(3) of the Exchange Act, or any successor definition.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Q.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">NOTICE OF EXERCISE shall mean the notice of exercise in the form approved by the Plan Administrator from time to time.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.84pt"> OPTION SHARES shall mean the number of shares of Common Stock subject to the option as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.94pt"> OPTIONEE shall mean the person to whom the option is granted as specified in the Grant Notice.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">T.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">PARENT shall mean any corporation (other than the Corporation) in an unbroken chain of corporations ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">PERMANENT DISABILITY shall mean the inability of Optionee to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which is expected to result in death or has lasted or can be expected to last for a continuous period of twelve (12) months or more.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">PLAN shall mean the Corporation&#8217;s 2002 Stock Incentive Plan, as amended from time to time.</font></div><div style="margin-bottom:10pt;padding-right:-15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.07pt">PLAN ADMINISTRATOR shall mean (a) the Corporation&#8217;s Human Capital Management and Compensation Committee comprised of Independent Directors, each of whom is also a Non-Employee Director, or (b) a majority of the Corporation&#8217;s Independent Directors.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">SERVICE shall mean the Optionee&#8217;s performance of services for the Corporation (or any Parent or Subsidiary) in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Y.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.28pt">STOCK EXCHANGE shall mean the American Stock Exchange or the New York Stock Exchange.</font></div><div style="margin-bottom:10pt;padding-right:-1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Z.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:27.4pt">SUBSIDIARY shall mean any corporation (other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="padding-right:-1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:76.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>s-8_exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iec46d6e2eda5453fb54fcb1ad18ca517_33"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:right;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 23.1</font></div><div><font><br></font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Ligand Pharmaceuticals Incorporated 2002 Stock Incentive Plan, as amended and restated of our reports dated February 28, 2022, with respect to the consolidated financial statements of Ligand Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Ligand Pharmaceuticals Incorporated included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">San Diego, California</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 13, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lwheadera.jpg
<TEXT>
begin 644 lwheadera.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $QI+"!*96YN
M>0  !9 #  (    4   0HI $  (    4   0MI*1  (    #-C4  )*2  (
M   #-C4  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M%%4-1US3M*CB>^NEC$W^K"@N7^@4$D>]1MXBTM=*341=;[21MBR1QL_S<\$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&TF^T"X^R?8^"YGSC9GI^- '045C:;KL]QJK:;JFGG3[ORO.C7SA(LBYP<$
M<CTK9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4455U"Q&H6OD-<7-N-P;?;2F-OID=J +5%<7IVC/=>(M
M9LI=8UCRK-H1%B^?/SQ[CGUYK8NO$UK8W4EE#:W]^]JH\][:+S!%Q_$21SCG
MO0!N45S<^JB]\1^&Y=/N7:SNX[EBJL0LF$7&X=R#GKTK:L+[[?%(_P!EN;;R
MY6CVW$>PMC^(>JGL: +5%4-:U/\ L?29+WRO.V,B[-VW.YPO7!_O9J;49+R+
M3Y7TV!+BZ 'EQNVU2<]S[#G\* +-%<UX1FU&2YU>/5[G[1/%<A3M)V)\@.%'
M8<U/XPNKFUT>)K>>2VB>YC2YN(AEH8CG<P].W/O0!O45R.B7ZV^N7T5GJ=QJ
MFE0V@F>:63S?+D!^Z'[Y7G%8VCWL4EG97.L7OB*$W#\W/GNMMN+'"YSTZ#IB
M@#T>BN(U:\#^(-4CUC6KK24MXE-E'#-Y8D&WEO\ ;.[M^%=+X=N;R\\.V4^I
M*5NI(@9 5P3Z''N,'\: -*BO/[O4#<ZYK$UU)KWV:VG$2C3I&$<050&+<COD
M\5OOI]QJT.G#3]7G725B+/-%.PGF)^[E\=/7O0!T-%<?IYU6;^WM+TO4VG%O
M)&EO=W+%FC+#,B[L')'3ZFG:=*;/QC#IVG:M=:E#Y4GVY9Y?-$#+C:=W8DY&
M* .NHK#\97LEAX4NY8)7BF;;'&\9(8%F XQSTS6;H<MFFNQ027&OPW)1FBAU
M.9MDPQR0,D$CK0!UU%<=J>L7E[X@T]K"9HM-AU%;5V1B/M#D,6''55VX]R3Z
M5;FCN=>\4W]DU_=6=IIT<8"VDOEL[N-V2>X [4 =-17#1ZKJ=Y;V>AF\=+IM
M0FLYKN,X=HXAN)![$@CFM73#/I/BQ]'DO9[NVGM?M,+74F]T8-M9=W4@CF@#
MI***X5);6Z\2:U'J_B&ZL%AG58(QJ!A&"O. 3_*@#NJ*PHK_ $_0='CFCO;K
M5([F;;"PF^TO(QXVJ<]/E/XYI]KXGAN9KBW_ +/U"&Z@A\_[-+"%DD3.,K\V
M#SQUH VJ*QK?Q3I]V^GI9B6>2_!9$11F)1]XOD\ '([\CC-7[.^^V2W*?9;F
M#[/*8]T\>T2?[2>J^] %JBJ&MZG_ &-HMSJ'E>=Y"[O+W;=W('7!QUJQ>R7$
M5C,]E")[A5)CC9MH9NW- $]%<UX8FU5]9UB+6KA9)HS"PCC)\N+<I.U0?PY[
MXJUXON[RS\.2RV#/&V]1)*@RT49/S,!["@#;HKD-$O GB@6NE:K<:KI[6OF7
M#SS>:(7S\N'[9_NUBV&HQ75J;_5[OQ%#'/.Y-Q#*Z6\0+G:.O Z=!CM0!Z31
M7&ZQ>)+XHN(-6UFYTJRCME>T,$WE+,3G<V[^(C@;>];7A2ZO+WPU:SZCN,S!
MAO88,BAB%8CMD8_G0!L45PFI7QN?%&J+(^NO;V@B15TMV54^7+%N1W/UX-:Z
MV<VL:5I8T?5[A=-;<\\YF;[1(.RAL>N0>F,4 =)17(Z>^I1:MK6E:7?O=K#"
MAAFO',GDRM_"6QSZX]JAB:;2_$NF65GK-UJ5U(Q%_!+/YJHNWEL?P8/0?2@#
MM**RO%%Z^G>%]0N8BRR+"0C*<%6/R@CZ$US^ARVT>IV45Y=^((;F1<Q_;IF$
M-PP'( )Y]<'% ':T5Q^NZQ>7&M64.FR/%96NHP0W,J$CS9&89CXZ@#K[D"D\
M3WDLGBFUL5?5/)CM&F>/3&*N[%L#."!@;3U]?>@#L:*XEM40Z':V>BZC?">^
MU 6TCWCEY[?CYQST( ''O6A:K<Z'XLMM/-[=7EG?P.R?:I?,9)$P3@GG!!Z4
M =-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-W=1V5E/
M=3Y$4$;2/@9.%&3_ "J:LWQ'_P BKJO_ %Y3?^@&@!-#\06/B&UDGTXR%(WV
M-O3;S@'^M:=<'\)_^0#??]?7_LBUWE !113995AA>60X1%+,?0"@# U?QOHV
MB:@UE>R2^<BAF$<>X#-;MO/'=6T<\#;HY4#HWJ",BO#+F*Y\1W&LZPN=L)\Y
MAC^$M@#\!_*O2?AMJGV_PNML[9ELG,9_W3RO]1^% '75R3_$KP_'(R,]QE6*
MG]R>U=;6"W@GPX[EFTJ(LQR3N;D_G0!G_P#"S?#W]^Y_[\FKND>-]'UO44L;
M%IC,X) >(@<#)YKSKP=I5CJ/C6>SO;=9K=5E(C).!AL"O4+#POHNEWBW5A81
MPSJ" ZDY /7J: +][=Q6%C-=W&1%"A=]HR<"J&A>)-/\11S/IID(A(#^8FWK
M_P#JI?%'_(J:G_U[/_*N0^$G_'IJ?_72/^1H ]$K#G\7:7;^(%T:1IOM;.J
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M-]J2$.8S.ULWE@@X.6QCK70JRNH9"&5AD$'@B@!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** ,+2;>:/Q;X@FDAD2*9K?RW92%?$6#@]\&N?GT^ZTS6M3,W]NA+JX
M:XA?2@&1PW9OE)# \<\?U[VB@#BM)TBXLM0\-?Z'=1)&+MY1*XD,.\# 9E4
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MRN$7;_%AN:CU'4=7U;P_-H]QHMRNI3_NGD6(BW4;OOA\D8Q^-=I10!Q*V?\
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M' /. !UKIJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&/[E69GP>/[Q!XSTK1TS2]4TCPPT%K):S:M)(TLDLY8QN[/EB<8/W?U%;U%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&K#;SP,L>N:T->OY=+T&\O;=4:6"(NH<$J3[XQ7,PS16]UX(DGD2)!8299V
M _<Q]S6MXIO;6Z\(ZHMM<PS,+<DB.0,0/PH L:AK36'A/^U&16F:!&2/G#2,
M!@>N,G\J30]5N]5TFX\Y(8M2MI)()4 .Q9%Z'&<[3QW]:PKXW>JSZ#I.FF#?
M:VT=]+YX)3@ ("!SU)X^E3:>=0T;QM_Q-VM=NLQX!M@53S8QQ]XDY(/XG% #
MY]4\40:[:Z6S:09+F-Y%<12[0%]?FJ6YU3Q#'K-EI,1TS[3-;O-)(T<FSAB
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MS6CX0O+JX74+>:\.H6UK/Y=O>D<RC&2,]\'O0!TE%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %1SP0W,+0W,231.,,DBAE;Z@U)10 BJ$4*H"J!@ #
M@"HC9VK-.S6T)-PH68F,?O0!@!O48)'-344 -CC2*-8XE5$0!551@*!T %5X
M]+L(=GE6-LGEN9$VPJ-K'JPXX)]:M44 0K:6R232);Q*\^/.8( 9,# W'O\
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MS%3PPQ6\*Q01I%&O"HB@ ?0"GT4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MULURWABXNKKQ3X@EOH%MY<6RF)'#[,*_!8<$\\_6NIH **** "BBB@ HHHH
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M:2 QKIB%_,+Y\T+D-QCC!&.]9Q\.ZE)H&HSRQHNJW-V+V&*.08B=2-JANF<
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M'GJ*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.2.W-=-6?>Z5]LUK3;_SMGV RGR]F=^]-O7/&.O>M"@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M51;Z1'9SW+0K#!]J:60JLBL2S,Q7MQBNCU.PN;CQ-H=W#'N@M6G,S[@-NZ/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+]T<<<=: .GHKA]#UZ]N=3LXKC78VG=L7-A>6GD,O'1"!R0?4\UW% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-W:0WUG+
M:W2!X9D*.I[@U-10!S(\,ZJME_9Z>(YA8[=@0VRF4)_=\S/IQG%7(?#4%KJF
MFW-I)Y4.GP/"L.S.[=WW9Z_A6U10!SVH^%?M_P#;/^F>7_:C0-_JL^5Y6/?G
M./;'O4EYX?NO[5N+[1]4;3Y+I5%PI@$JN0,!@"1@XK=HH Y9/!C64]K<:1J1
MMIX(#"\DMNLWF98N6Y(P<D\^F!5;4/#L.F:/JL^IW=U>BZECF:6&$>9#(O\
M'@'! )S@#@<<]:[*B@#@=.E?6/&&ER+J[:S':I,9G6U\J.(,A4 CNQ)K6'A"
MZ2Q?3(=;FCTER0;;R5+A"<E!)G@?A7444 ,AA2W@CAA79'&H1%'8 8 I]%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "HYX(;F%H;F))HG&&210RM]0:DHH HPZ'I-
MM,LMOI=E%(IRKQVZ*1]"!4]U96M]&([VVAN4!R%FC#@'Z&IZ* *HTRP$;QBQ
MM@DFW>HA7#;?NY&.<=O2EMM.LK.1Y+.SM[=Y/OM%$JEOJ0.:LT4 4CHVEF:2
M4Z;:>9("'?R%W-G@Y..<U/'9VT,JR16\22+&(E=4 (0=%!]/;I4U% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1I(D;R*KR9V*6 +8&3@=Z?0 4444 %%%% !1110 444V21(HVDE=41 69F.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L'Q
MM_R)>I?]<A_Z$*WJH:WIG]LZ+<Z?YOD^>NWS-N[;R#TR/2@#/TO4-<:.TCET
M.*. J@:87P)"X'S;=OZ55LKG6-1\1:K&FI+#;:?<*%A,*GS 5SM+8R!QU'//
MM72P1>1;1Q9W>6@7.,9P,5EVWA](9]8:6X9TU0_,JKM,8V[2 <G/7TH Y6^\
M2WVGP"X'B:TO;I)%\RQM[=6B(+8(#@9Z=R:VFEUK4O%&JV%EJ@LK:T6%E(MU
MD;+KG SVX).?;%0OX+OI=%&E/KV+2/;LC2S5<[2"-Q!RW3VYYK=L]*^R:WJ.
MHF;>;X1#R]F-FQ2.N><YH XJ]UZ>XTGP_J-\AGGM]0=7$*\RE<@8'J>*L:K-
MJ.K_  ]O=4GU)?+G D6VAC4JB9QY98C=G.,GVXK9MO"'V>'3X_MV[[%>M=9\
MG&_<3\OWN.O6G7'A+?:ZM:6U[Y%IJ.'$/E;A"^068<C@XZ<4 /LKC4+;Q9#I
M5U?&ZB736F9C$B;G\W / XPIQCI6-?\ B'5XH]3^SW2J\.K1VT.Z-2%0_P )
MXY^O7WKH-4T.XN]6AU/3=1-C=1PF!B81*KH3G&"1WK.'@IOLL\4FIM*\U['>
M/(\(R67J, ]S^7I0!3U#3M5C\7:"DVN232N+@I)]EC78 JDC &#D<<],5VU9
M.KZ--J&H6%[:7OV2>R+[28A(&#@ C&1Z=:UJ "BBB@ HHHH **** "LWQ%:P
MWOA^[M;FZ2T29-GG2, JDGC.?? K2JKJ6GV^JZ;-8WBDPS+AMIP1W!'N" :
M.3O[K4[/1S:>*M!AO-,C"K)/92XVJ/XMOWAT[8JYK.J/%<PE/$=KI=D\"M%A
M!+-*3W(8=,5-)X;U6YM397WB.6:R8;9$%LJR.G]TOG]<4Z;PQ/%J[W^C:D+$
MR1)$Z-;++@(,#:2>./K0!C1>(]6NM!LVMKR(W+ZQ]A^TF$!94PV&*D<=C@8/
M%;.F7&J6GBQ])U&_%_$]E]I20PK&R$.%Q\O4<TRV\(-;V\,3ZBTQBU0:B9'B
M^9SC!4\]23G/Z5JG2L^)AJ_G=+,VOE;/]L-NSGVQC% &5XU>6.'1GMXA-*NJ
MPE(R^W>=KX&>WUK1T^]UB>ZV:AH\=I#M)\U;P2'/I@**DU;2O[4:P/G>5]CO
M$NON;M^T$;>HQUZUH4 <=HMWKUYX5&L7&LVP>2%@B7$2QQ1D-MWLP&>@/'3)
M%06?B*>/Q'I]K#KZ:S#=.T<JBV6,1G;D$,HYY[5K?\(DC>#8M DO&/E\K.L>
M.0Y894D\<],TT>&+^74;"[O]:^T&QDW1QK:K&F,8(P#UZ<]L=* ,F"_\17F@
MZEJL>KI$+&2;;#]F0^8J9.&.....*O1ZKJFO:I%9Z?>+IR1V45S/(L(D9F<9
M"@-P !6A:>'/LOA_4=+^U;_MIF/F^7C9Y@QTSSCZC-1/X8GADM;C2M3-G=PV
MJ6LLA@$BS*HX)4G@_C0!&+O6;+6M$L-1NH9?M$EP)6BC \U%CRA((^4YZ@<5
MC6_B+5&OE2]UF.PO?/PVGW=ILBV;NBR8)/'0YK=L_"BVEY87)O7EEMIIYYF=
M.9WE3:3P?EQQZU#<>%+Z\M387VO2W&G%PQBDMU,I&<X\PG/XXH (Y]:UW4-2
M.GZDNG6UE.;:-! LAD=0"2Q;H.1TIK7>NWVLQZ1'>0V,MO:K-=W$,0DWN3@!
M0W;C/(JU<>'+M+Z[GT;5WT]+T[IX_($F7Q@LI)&TFH_^$1^QM:RZ%?O83V\'
MV=G:(2B5,Y^8<<Y).: +&@7][+=ZCINJ.D]Q82*!<(NWS4==RDJ.A]<5MUF:
M-HPTH7$LMR]W>7<GF3W#J%WD<  #H .U:= !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 445F^(M1FTCP]=W]LJ-+ FY1("5/('."/6@#2HJG+=R)HCW@"^8MN90
M".,[<_E532]<BF\.66HZK/;6IN(PS%G")GT&X_UH UZ*K)J5C):&ZCO;=K<$
M*9A*I0$D #=G'4C\Z8NL:8ZRE-1M&$(S*1.I\OG'//'XT 7**P]=\0"RT)=0
MTJ2VN@TZ1A@V]""V#RIZUIVVHV5Z[I9WEO<,GWEBE5BOUP>* +-%5_[0L_L/
MVW[7!]EQGS_-'E]<?>SCKQ39]4T^UD,=S?6T+J0"LDRJ03TX)[X.* +5%5)=
M6TZ"X,$]_:QS*,F-YE# 8SG!.:LQR)+&LD3*Z. RLIR&!Z$&@!U%%% !1110
M 4444 %%%4M8U)-(T>YOY$,BP)NV XW'L,]N: +M%<Q)J7BFVL8]0DL["\@(
M5FMK02&7:?0\AB,^E;USJ-E91I)>W<-JLGW3/((\_P#?6* +-%1&[MUM?M+3
MQ"WQN\TN-N/7/2H[?4K&[A>:UO+>>*/EWCE5E7ZD'B@"S15=K^S6T2Z:[@%N
M^-LQD&QL],'H:H:1JT]_J^KVLR1JEE,L<90')!7///\ A0!KT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@^-O^1+U+_KD/\
MT(5O5'/!#<PM#<Q)-$XPR2*&5OJ#0!RTWAJ-?#LDW]JZL<6A?8;U]OW,XQZ>
MU8]I=VPT_P /VQL;.>\%B9(YK^?9#&I.#QR&/'IGBO0S%&83$44QE=I0CC'3
M&/2JTNDZ=/;Q03Z?:R0P\1QO"I5/H".* /-Y&630_%@4VA0SVG%EGR<[P#M_
M$<GUKHK[2-.3Q]HT"64"P_9I28Q&-K;>F1WQ[UTW]E:=Y<B?8+79(%#KY*X<
M+]T'CG';TJ9K:![E+AX8VGC!5)2@+*#U /44 ><ZO#;P:7K\!01VJZM#E$&
MH(7. *V9QIO_  F&A?\ "/"V\P"3S_LN,>3M_BQQUZ5U3:?9/OWV<#>8XD?,
M2G<PZ,>.2/6BUTZRLF=K*SM[=G^^8HE0M]<#F@#SQ]1LT^#HM&N8OM)79Y.\
M;PWFYQMZCCFN@M;.VNOB1JIN8(YBEK#M\Q VWZ9^E;S:-I;R22/IMFSR\2,8
M%)?ZG'-6%MH$N7N$AC6>0!7E" ,P'0$]30!Y];_V*? FI?VO]G_M3,_G^;CS
MO.W';COZ?YS7;Z%_R+NG?]>L7_H KG[WPWK-XUQ%+_8\OG[D-^]OBX6-N",
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M[);BXE\TVA0#[++UV8Z[<4S1=<>R\.Z)I]A9-?7T]KY@B$@C5$'&YF.<<\4
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M/M\[6,8*B01*!GDDG./IS0!V=%<_!XFFNM(^T6VDW$MV+DVKVJL/W;CKN?&
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MXY.1Q72^'+"YL%U,7<?E^?J,\\?S [D8C!XZ?3K6S10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %07U[;Z=92W=[)Y<$0R[[2<#Z#FIZP?
M&W_(EZE_UR'_ *$* -EKF)+0W+-B$)YA;!^[C.<=>E)9WD%_9Q75H_F0RKN1
ML$9'T/-<Q-J.O'P[(C:#$(OLA!D^WCA=G7&WT[54T6[U&YT_1-'TNX6RS8?:
M9KDQB1@N[:%4'CKZ_P#ZP#N**XC4->UC2['6+*>[66[LO(DANUB4;D>100R]
M,\D=*WM3O[FW\3:':0R;8+IIQ,FT'=MCR.>HY]* -FF+-&\KQI(K21XWH&!*
MYZ9';-<);^(M4:^5+W68["]\_#:?=VFR+9NZ+)@D\=#FG+<7NBZWXIU%KUKC
M[*L3-$T2@2EH_DR1R N0..M '>45R-U<^(-#L[74[_4H[R)I$6YM?(5 @<X^
M1ASD$]^M,CNM=U*YUL6VK+:1Z?<.L0%LCEAMR%)/88^O)YH [&BLWP[J,NK>
M';*^N HEFCR^WIG.#_*M*@ HHHH **** "BBB@ ILDB11M)*ZHB LS,<!0.I
M)IU9OB*UAO?#]W:W-TEHDR;/.D8!5)/&<^^!0!6A\8Z#/.D4>H+EVVJS1NJL
M?9B,?K5NYUS3K.:YAN;C8]K")YAL8[4)QG@<_0<US-_=:G9Z.;3Q5H,-YID8
M59)[*7&U1_%M^\.G;%,\0:K-<C6K..?S+%=)2:)<#JQZYZG(]30!UT.J6=Q>
M):Q3;IGMQ<JNTC,9. V<8Z]NM6ZX_P#MZXTN8*6WVMOH"70AVCF3=C.>OH.M
M7=,@\1R1V5_+JT$ZS;7FM6MPB*C#.%8#=D>] '1T5QD%[XBU#P_)X@@U**!-
MKS16)MU9"BD\,WWLD ]#3H-4U?7-=%O87XT^WDT^&[_U*R,I8=!D>_?TH [&
MJMMJ-K>75S;6\N^:T8+,A4@H2,CJ.?J*S_"]_>7VGW*:C(DMQ:7<MJTJ+M\S
M8?O8[=:JW@_LKQU9W8PL&J1&VE_ZZ+RA^I'% &V^HVL>IQ:>\O\ I4J&1(PI
M.5'4YQ@?C5FN6TMI;[4-;UV)H@0#:6;SL0BI'U8G^Z6Y_"LQ?$5U;:EIR)XD
M@U1Y[J.">VBME"*&."5<#L>G/- '5OX@TR.*21[G"177V1SY;<2\?+T]QST]
MZT:\YO?^07J/_8S_ /Q-6KOQ3+/JFHH?$,&D+:S-!# UN)#(5X+,2#@$\<4
M=Y17)6'B2\NFT'4)6"V6HJ]M-&%&%G!(5@>O)4C&:U- O[G5)M1NWDW6?V@Q
M6B!0/E3AFSU.6SU]* -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H:WIG
M]LZ+<Z?YOD^>NWS-N[;R#TR/2K]% %:2S\S26LM^-T!AWX_V<9Q6(GA-[>VT
MXV&I-;7UC#Y N!"&65#SAD)]>>M=)10!S9\(+<:?J,>H7\ES=ZAL\RZ\L+MV
M$%0J]@".F:?#X<OFUFQU'4]9:\>SWA4%N(U(9"IZ'@\@Y]NU=#10!S%QX4OK
MRU-A?:]+<:<7#&*2W4RD9SCS"<_CBK-QX9^TZKJ,\MWFSU*-4N+;RADE5VJ0
M^>,=>E;U% '-+X5NYA:V^J:S)>6-JZNEOY"H7V_=#MD[@/IS5^QT/[&^K-]H
MW_VC*TGW,>7D8QUY_2M:B@"AHFF?V-HMMI_F^=Y"[?,V[=W)/3)]:OT44 %%
M%% !1110 4444 %5=2T^WU739K&\4F&9<-M.".X(]P0#5JB@#FY/#>JW-J;*
M^\1RS63#;(@ME61T_NE\_KBG7OA)+J>^:*Z\F.ZLELUC$6?+"G@YSS]*Z*B@
M##'AF)KSS;B;S8FTP:>\6S&X YW9SQUZ?K5>#PK=9LX;_6)+NQLI%DBMS JD
ME?NAFS\P'TKI** .7_X1&ZBM)=.L];E@TN4G-L(%+JK'+*KYX'7MWK1L= CT
M_6WOH)<1?9$M4@V?="=#NSS^5:]% &?I&E?V4MZ/.\W[5>277W-NW><[>ISC
MUI-<TG^V=-^SK.;:99%EAG5<F)U.00,CW'XUHT4 9'_".V__  B?]A>8RQ>3
MY9D48)/4MCW/.*S?^$3U"1+%+G7!)'8S1S0QK9JBDH<_, V3^?>NIHH YR;P
MEYUK<P_;<>?J?]H9\K[O3Y.OMU_2I)?#M[#=W4FC:PUA%=N998C;B7#G[S*2
M1@FM^B@#DO$Z067A>+2#=3W.I.4-HSDO+)*''S9_'\JZ+2;!-+TBUL8^1!&%
M)_O'N?Q.35NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7[-]J!?_ (]=O^JV?Q>WUJA;?V!_PK:?[5]G^W^6_F;\>?\ :,G'^UG./PH
M[VXU33[20I=WUM ZXRLDRJ1GIP3WP:)M4T^VN1;W%];13MC$4DRJQS[$YKE-
M)M%N_&C?VK LTZ:3 7$Z!B'XW=>]8ELLKV6KB_70Q*\\OVEK^1EG7TP IXQT
MQ0!ZA169X;\W_A&K#[1,L[^0O[U0P#CL?F /3'45IT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5@^-O^1+U+_KD/_0A6]63XILKC4?#%]:6
M4?F3RH B;@,G([GB@"_8?\@ZV_ZY+_(5@-XLNI8+B]T[19+K38&93<^>JLX7
M[S*F.1U[BK%AJ.M*+:WG\.RQQC;&\INXB%' +8!R?7%9L%IXATK1Y]$M--CN
MXR9$@O/M"JH1R3\RGG(R>E %V3Q8UQ?16NAV OW>W6X)>X6'Y6Z 9!R?7TK9
MTV\>_P!.AN9;66T>0'=#,,,A!QC]/RKE+OP[<0V]G93:%!K%O;VR1QS1SB&9
M''WLL2,KGD8Z5O>&+&^T[0XX-3D+S!F(4OO,:D\+N[X'>@#(\56TGB'5XM$M
MW(%O;O=2%6QAR"L0/X\_2K47BGRO R:W+"9I8PB31!L'?O"-V..3G%0V/A6#
M4[F^U#Q+8*]S<7+&)'?=Y<0 "CY3CH*H7OAK4+:QUO2M*L]UA<O#/:CS5 5@
MZ;UY.>@S^'K0!M6_B*[&KVUEJNDM8+=J[02&X5\[1N(8 ?*<?6J4WC.[32I=
M6@T*2735SLG-PJLX!P#LQD#/?FM#6M+GU#7]'E2,M;0BX6=PP!0/%M'7D\^F
M:Y6^GU6P^'L^G_9+>:SCC,::C'=(R2)NXPHYR>E '47'B.X:^2RTG33?7(@6
M>8&<1K$&Z#<0<D^F*S-5U=-8L-(E$+V\T.N00SP.<F-PQR,]_K4-]X:F_M,7
MYTMM3CN+>)7B6[-N\+HN/[P!!'KR,?FZ#PW>1:=9>7IT-M+_ &O#=2PQSLY2
M)3U9G8Y8#^[^5 &E+XGO)9[PZ3HSWUK9N8Y9_/5,LOW@JX.[%+/XM622QBT>
MS^VRWL)G023"$!<XQDYRV>,"L.7PK<65U>HNB-J:S3/+!<+J#0A0W.UEW#H>
MXZU=NM!N8]*T^RD\/V6I6T41WQ0S&-X9"<G:[MG;SZYS0!TFE7TVH69ENK&:
MQF5V1X9>>1W![CWJ[6%X4TZ^TW3IH[[=&CS%H+9I?-,"=EW=ZW: "BBB@ JK
MJ&FVFJVOV?4(%GAW!MC9QD?2K5% '#Z7X5T2?Q1KMM+I\;0VS0")"3A-T>3W
M[FM>3Q!=&[N;70M':^BL2(I9#.(@& ^XH(.X@?2K&F6%S;^)M<NYH]L%TT!A
M?<#NVQX/'4<^M48X=;T.^U%;#3EU&WO)VN8G$ZQF-F'*L&ZC([4 4;WQ#8W&
ML>'-8>3R+81W9D\SJA"J"I'KGCWK4_X2:YCMK.[N]+-M:W=T(%:2?#HK?==E
MV\9],UDQ>#)7.B0:E ES#']JDO"&&U'D *X[GGT[C-74TJ]?PCJ.C:O_ *NW
M0K:WC./WB#E&/)(*X&: -"_\2P:?J-W#-$3!96HN)YE;E6)PJ!<<D]>HJLGB
M>\@FM#J^C/8VMVZQQS^>K[6;[H=<#;FL[2M'NM=\$WLUU($OM8(F\QL\!<>6
M#[?+^1JQ=V^O:^+*SU#3$L889TFN)_M"OOV\X0#D9/K0!UE%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%07U[;Z=92W=[)Y<
M$0R[[2<#Z#F@">BH+*]M]1LHKNRD\V"491P",CZ'FH--UK3]7,XTZX$_V=]D
MF%8;3^(YZ=J +U%%07U[;Z=92W=[)Y<$0R[[2<#Z#F@">BFQNLL:R(<JP# ^
MH-06.HVNI0O+92^:B2-$QVD88=1R* +-8J^$-"2Z%PNGH'5]X7>VP-Z[,[?T
MK2^WVW]IC3_,_P!*,/G^7M/W,[<YZ=>W6K% !1110 4444 %%%% !1110 44
M56O]1M=,A26^E\J-Y%C5MI/S'H.!Q]: +-%4=2UFPTCR?[1N!#Y[^7'E2=S?
M@#CZU+=:C:V4UM#<R[)+J3RX5VD[F].!Q]30!9JIJ6EV>KVPM]0B\V(,'V[V
M7G!'8C/4\5;HH ;'&L4:QQJ%1 %50. !VIU5GU&U34X]/>7%U)&94CVGE0<$
MYQBEO[^VTRR>[OI/*@C(#/M)QD@#@<]2* +%%%% !12,P12S$*H&22> *2.1
M)8UDB971P&5E.0P/0@T .HHHH ***S-2\0Z9I%RD&H7#1RR+O55A=\C.,_*#
M0!IT5FZ;X@TO5YGBL+H22H,M&R,C >N& -:+,J(6=@JJ,DDX % "T5ACQEH!
ME$8U%>6VA_+?9G_?QM_6MP'(R.10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@^-O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMKAU&2L4RN1^ - %JBJ1UK2PT:G4K,&3.P>>OS\XXYYY!%7: "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
